Anjarium Biosciences AG is a genetic medicines company focused on creating and delivering a new generation of targeted gene therapies to patients. Anjarium’s versatile platform builds on novel therapeutic payloads and delivery technologies, with the aim to unlock the full potential of gene therapy.
Location: Switzerland, Zurich, Schlieren
Employees: 11-50
Total raised: $61M
Founded date: 2017
Investors 3
| Date | Name | Website |
| 15.01.2022 | Omega Fund... | omegafunds... |
| 06.08.2021 | Abingworth... | abingworth... |
| 16.06.2022 | GIMV | gimv.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.09.2021 | Series A | $61M | - |
Mentions in press and media 16
| Date | Title | Description |
| 13.01.2023 | Seasoned executives to drive startups in the next phase | |
| 30.12.2022 | Experienced members on startups' board | |
| 16.12.2022 | Newly hired executives to boost their company’s growth | |
| 20.07.2022 | Executive seats taken at six startups | |
| 29.06.2022 | New C-Suite leaders assume responsibility to boost startup growth | |
| 28.01.2022 | Schlieren biotech unlocks the potential of gene therapy | |
| 20.09.2021 | Digital health news, funding roundup in the prior week; September 20 | Biden administration seeks to expand telehealth; BetterUp acquires Motive and Impraise Biden administration seeks to expand telehealth in rural America. New funding will allow more medical appointments to take place via video in rural commu... |
| 18.09.2021 | Daily funding roundup - September 18th, 2021 | Francis Medical raised $55M; CodeSignal landed $50M; Ketch secured $23M; Roboflow picks up $20M Whatnot: Whatnot is a L.A.-based startup that hosts live-streamed video sales and auctions of Pokemon cards and other collectibles. Whatnot has ... |
| 17.09.2021 | Daily funding roundup - September 17th, 2021 | Francis Medical raised $55M; CodeSignal landed $50M; Ketch secured $23M; Roboflow picks up $20M Whatnot: Whatnot is a L.A.-based startup that hosts live-streamed video sales and auctions of Pokemon cards and other collectibles. Whatnot has ... |
| 16.09.2021 | Anjarium Biosciences Raises CHF 55.5M ($61M) Series A Financing to Develop Next-Generation Non-viral Gene Therapies | - |
Show more